Aberrant ING5 expression has been demonstrated in several cancer subtypes, for example, down-regulation of ING5 mRNA was found in squamous cell carcinoma of the oral cavity, and tumor-suppressive function of ING5 has also been found in acute myeloid leukemia (AML) [50,51]. This evidence concerns the gene ING5 and acute myeloid leukemia.